[ORGANIZATION]
H. C. Wainwright
Featured in 5 tracked stories · first seen
Situations
Novartis remibrutinib Phase III clinical trial results
2 clusters · 14 sources · last updated
Latest: Novartis reports positive Phase III results for oral MS drug remibrutinib
Novartis has reported positive topline results from two Phase III clinical trials, REMODEL-1 and REMODEL-2, evaluating its experimental oral drug remibrutinib for the treatment of relapsing multiple sclerosis. The drug,
2 clusters · 4 sources · last updated
Latest: SBC Medical announces September 2026 investor conference schedule
Orchestra BioMed corporate developments
2 clusters · 4 sources · last updated
Latest: Orchestra BioMed and Immunocore announce investor conference appearances
Orchestra BioMed Holdings, Inc. has moved from reporting financial forecasts and insider trading activity toward presenting its clinical developments at investor conferences. In early August, the company prepared to rel
Also covered in
-
BioVersys AG to present at H. C. Wainwright Global Investment Conference
[BUSINESS] · 2 sources ·
-
Chaince Digital seeks to increase authorized shares to 20 billion
[BUSINESS] · 2 sources ·